COVID-19 Infection, Progression, and Vaccination: Focus on Obesity and Related Metabolic Disturbances

Overview

Journal Obes Rev

Specialty Endocrinology

Date 2021 Jul 16

PMID 34269511

Citations 26

Authors

Annemarie J F Westheim

Albert V Bitorina

Jan Theys

Ronit Shiri-Sverdlov

Affiliations

Soon will be listed here.

Abstract

Coronaviruses are constantly circulating in humans, causing common colds and mild respiratory infections. In contrast, infection with the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for coronavirus disease-2019 (COVID-19), can cause additional severe complications, particularly in patients with obesity and associated metabolic disturbances. Obesity is a principal causative factor in the development of the metabolic syndrome; a series of physiological, biochemical, clinical, and metabolic factors that increase the risk of obesity-associated diseases. "Metabolically unhealthy" obesity is, in addition to metabolic disturbances, also associated with immunological disturbances. As such, patients with obesity are more prone to develop serious complications from infections, including those from SARS-CoV-2. In this review, we first describe how obesity and related metabolic disturbances increase the risk of SARS-CoV-2 infection. Then, mechanisms contributing to COVID-19 complications and poor prognosis in these patients are discussed. Finally, we discuss how obesity potentially reduces long-term COVID-19 vaccination efficacy. Despite encouraging COVID-19 vaccination results in patients with obesity and related metabolic disturbances in the short-term, it is becoming increasingly evident that long-term COVID-19 vaccination efficacy should be closely monitored in this vulnerable group.

Citing Articles

Short-term side effects of BNT162b2 vaccine in primary care settings in Qatar: a retrospective study.

Abdeen S, Alah M, Al-Zaidan M, Ibrahim M, Abdulmajeed J, Al-Nuaimi A Front Public Health. 2024; 12:1384327.

PMID: 38660363 PMC: 11039914. DOI: 10.3389/fpubh.2024.1384327.

Cholesterol and COVID-19-therapeutic opportunities at the host/virus interface during cell entry.

Grewal T, Nguyen M, Buechler C Life Sci Alliance. 2024; 7(5).

PMID: 38388172 PMC: 10883773. DOI: 10.26508/lsa.202302453.

Associations of Temporal Cardiometabolic Patterns and Incident SARS-CoV-2 Infection Among U.S. Blood Donors With Serologic Evidence of Vaccination.

Yu E, Stone M, Bravo M, Grebe E, Bruhn R, Lanteri M AJPM Focus. 2024; 3(2):100186.

PMID: 38304025 PMC: 10832374. DOI: 10.1016/j.focus.2024.100186.

Dose Intervals and Time since Final Dose on Changes in Metabolic Indices after COVID-19 Vaccination.

Alghamdi A, Wani K, Alnaami A, Al-Daghri N Vaccines (Basel). 2023; 11(12).

PMID: 38140151 PMC: 10748310. DOI: 10.3390/vaccines11121746.

The causal relationship between air pollution, obesity, and COVID-19 risk: a large-scale genetic correlation study.

Zhang J, Wen J, Wan X, Luo P Front Endocrinol (Lausanne). 2023; 14:1221442.

PMID: 37867515 PMC: 10585274. DOI: 10.3389/fendo.2023.1221442.

References

Mercer J, Schelhaas M, Helenius A . Virus entry by endocytosis. Annu Rev Biochem. 2010; 79:803-33. DOI: 10.1146/annurev-biochem-060208-104626. View

McGonagle D, ODonnell J, Sharif K, Emery P, Bridgewood C . Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol. 2020; 2(7):e437-e445. PMC: 7252093. DOI: 10.1016/S2665-9913(20)30121-1. View

Hollstein T, Schulte D, Schulz J, Gluck A, Ziegler A, Bonifacio E . Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report. Nat Metab. 2020; 2(10):1021-1024. DOI: 10.1038/s42255-020-00281-8. View

Billah M, Miah M, Khan M . Reproductive number of coronavirus: A systematic review and meta-analysis based on global level evidence. PLoS One. 2020; 15(11):e0242128. PMC: 7657547. DOI: 10.1371/journal.pone.0242128. View

Falagas M, Kompoti M . Obesity and infection. Lancet Infect Dis. 2006; 6(7):438-46. DOI: 10.1016/S1473-3099(06)70523-0. View

Eckel R, Alberti K, Grundy S, Zimmet P . The metabolic syndrome. Lancet. 2010; 375(9710):181-3. DOI: 10.1016/S0140-6736(09)61794-3. View

Lighter J, Phillips M, Hochman S, Sterling S, Johnson D, Francois F . Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission. Clin Infect Dis. 2020; 71(15):896-897. PMC: 7184372. DOI: 10.1093/cid/ciaa415. View

Jeurissen M, Walenbergh S, Houben T, Gijbels M, Li J, Hendrikx T . Prevention of oxLDL uptake leads to decreased atherosclerosis in hematopoietic NPC1-deficient Ldlr mice. Atherosclerosis. 2016; 255:59-65. DOI: 10.1016/j.atherosclerosis.2016.10.038. View

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

10.

Karlsson E, Sheridan P, Beck M . Diet-induced obesity in mice reduces the maintenance of influenza-specific CD8+ memory T cells. J Nutr. 2010; 140(9):1691-7. PMC: 2924599. DOI: 10.3945/jn.110.123653. View

11.

Hotamisligil G . Inflammation and metabolic disorders. Nature. 2006; 444(7121):860-7. DOI: 10.1038/nature05485. View

12.

Bert N, Tan A, Kunasegaran K, Tham C, Hafezi M, Chia A . SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature. 2020; 584(7821):457-462. DOI: 10.1038/s41586-020-2550-z. View

13.

Tadic M, Saeed S, Grassi G, Taddei S, Mancia G, Cuspidi C . Hypertension and COVID-19: Ongoing Controversies. Front Cardiovasc Med. 2021; 8:639222. PMC: 7925389. DOI: 10.3389/fcvm.2021.639222. View

14.

Dimitrov D . Virus entry: molecular mechanisms and biomedical applications. Nat Rev Microbiol. 2004; 2(2):109-22. PMC: 7097642. DOI: 10.1038/nrmicro817. View

15.

Ewer K, Barrett J, Belij-Rammerstorfer S, Sharpe H, Makinson R, Morter R . T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial. Nat Med. 2020; 27(2):270-278. DOI: 10.1038/s41591-020-01194-5. View

16.

Kruglikov I, Shah M, Scherer P . Obesity and diabetes as comorbidities for COVID-19: Underlying mechanisms and the role of viral-bacterial interactions. Elife. 2020; 9. PMC: 7492082. DOI: 10.7554/eLife.61330. View

17.

Milner J, Sheridan P, Karlsson E, Schultz-Cherry S, Shi Q, Beck M . Diet-induced obese mice exhibit altered heterologous immunity during a secondary 2009 pandemic H1N1 infection. J Immunol. 2013; 191(5):2474-85. PMC: 3756476. DOI: 10.4049/jimmunol.1202429. View

18.

Chen L, Li X, Chen M, Feng Y, Xiong C . The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res. 2020; 116(6):1097-1100. PMC: 7184507. DOI: 10.1093/cvr/cvaa078. View

19.

Njajou O, Cawthon R, Blackburn E, Harris T, Li R, Sanders J . Shorter telomeres are associated with obesity and weight gain in the elderly. Int J Obes (Lond). 2011; 36(9):1176-9. PMC: 3408817. DOI: 10.1038/ijo.2011.196. View

20.

Allard R, Leclerc P, Tremblay C, Tannenbaum T . Diabetes and the severity of pandemic influenza A (H1N1) infection. Diabetes Care. 2010; 33(7):1491-3. PMC: 2890346. DOI: 10.2337/dc09-2215. View